Back to Search
Start Over
Insulin Titration Algorithms Incorporated into a Patient Glucose Diary Result in Significant Improvements in Glucose Profiles and A1C
- Source :
- Diabetes. 67
- Publication Year :
- 2018
- Publisher :
- American Diabetes Association, 2018.
-
Abstract
- A 44-week, multinational RCT compared efficacy, safety, and subject preference for bolus insulin initiation using a wearable bolus insulin delivery patch (Patch, Calibra Medical) vs. an insulin pen (Pen, NovoLog FlexPen®) in 278 T2D subjects on basal insulin (0.52 U/kg) (A1C: mean ± SD, 8.7% ± 1.0, BMI: 32.6 kg/m2, duration: 15 y), using insulin titration algorithms incorporated into a patient diary. At randomization, basal insulin dose was divided 1:1, basal:bolus. Subjects used SMBG patterns weekly to adjust insulin doses. The diary also included algorithms for adjusting bolus insulin at each meal if SMBG was above or below target and if meal size was larger or smaller than usual. At 44 weeks there was significant (p In summary, by making weekly insulin adjustments based on simple algorithms embedded in a patient glucose diary, T2D subjects can significantly improve A1C values and 7-point glucose profiles. Disclosure M.L. Johnson: Research Support; Self; Calibra Medical, Medtronic, Sanofi, Novo Nordisk Inc., Abbott, POPS! Diabetes Care, National Institute of Diabetes and Digestive and Kidney Diseases, Dexcom, Inc., Hygieia, JDRF. D.M. Dreon: Employee; Self; Calibra Medical. B.L. Levy: Employee; Self; LifeScan, Inc. R.M. Bergenstal: Research Support; Self; Johnson & Johnson Services, Inc.. Consultant; Self; Johnson & Johnson Services, Inc.. Research Support; Self; Abbott. Advisory Panel; Self; Abbott. Research Support; Self; Becton, Dickinson and Company. Consultant; Self; Becton, Dickinson and Company. Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc., AstraZeneca, Takeda Pharmaceuticals U.S.A., Inc., Dexcom, Inc.. Stock/Shareholder; Self; Merck & Co., Inc.. Research Support; Self; Eli Lilly and Company, Sanofi. Advisory Panel; Self; Sanofi, Roche Pharma. Research Support; Self; Novo Nordisk Inc.. Advisory Panel; Self; Novo Nordisk Inc.. Research Support; Self; Medtronic. Consultant; Self; Medtronic. Research Support; Self; Hygieia. Advisory Panel; Self; Hygieia, Glooko, Inc.. Research Support; Self; JAEB Center For Health Research, JDRF, National Institute of Diabetes and Digestive and Kidney Diseases.
- Subjects :
- Randomization
business.industry
Endocrinology, Diabetes and Metabolism
Insulin
medicine.medical_treatment
Insulin pen
030209 endocrinology & metabolism
Patient diary
medicine.disease
law.invention
03 medical and health sciences
0302 clinical medicine
Bolus (medicine)
Randomized controlled trial
law
Diabetes mellitus
Internal Medicine
medicine
Insulin titration
030212 general & internal medicine
business
Algorithm
Subjects
Details
- ISSN :
- 1939327X and 00121797
- Volume :
- 67
- Database :
- OpenAIRE
- Journal :
- Diabetes
- Accession number :
- edsair.doi...........bf1410a292f291495b7f80a70c221a01
- Full Text :
- https://doi.org/10.2337/db18-710-p